We describe a 47-year-old 
Introduction
Thyroid hormones act on the cardiovascular system by increasing the heart rate and stroke volume (1) . Thyrotoxicosis increases the risk of heart diseases such as atrial fibrillation, heart failure, angina, and myocardial infarction (1) . Anginal chest pain was found to be a frequent symptom in thyrotoxicosis, occurring in 0.5-20% of patients (usually 10-12%) , and almost all of the patients had previous coronary artery disease (CAD) (5) (6) (7) (8) (9) (11, 12) 
or atherosclerotic lesions (2). A study in 1950 found that thyrotoxic patients frequently complain of anginal chest pain (3), and a relationship between thyrotoxicosis and coronary vasospasm was demonstrated in 1979 (4). A few cases were reported about their thyrotoxicosis complicated with angina or myocardial infarction induced by coronary obstructions and recovering normal coronary arteries after antithyroid drug therapy

. In addition, coronary vasospasm was found to be influenced by increased levels of serotonin, thromboxane A2, endothelin, and prostaglandin F2α and by decreased levels of endothelin-induced vasodilator or prostacyclin (13). Moreover, thyrotoxicosis causes vasospasm through increases in the density and affinity of beta-receptors in the vasculature
F i g u r e 2 . L e f t c o r o n a r y a n g i o g r a ms : i n i t i a l a n d a f t e r t h e a n t i t h y r o i d d r u g me d i c a t i o n . T h e i n i t i a l c o r o n a r y a n g i o g r a p h y s h o we d a 9 0 % o c c l u s i o n o f t h e l e f t ma i n o s i n t h e l e f t a n t e r i o r o b l i q u e p r o j e c t i o n ( A) . On d a y 1 9 a f t e r t h e i n i t i a t i o n o f a n t i t h y r o i d d r u g me d i c a t i o n , c o r o n a r y a n g i o g r a p h y i n d i c a t e d n o r ma l c o r o n a r y a r t e r i e s wi t h a p a t e n t p r e v i o u s g r a f t ( B ) . T h e a r r o ws d e n o t e t h e s a me c o r o n a r y a r t e r y l e s i o n b e f o r e a n d a f t e r t h e a n t i t h y r o i d me d i c a t i o n .
F i g u r e 3 . Ri g h t c o r o n a r y a n g i o g r a ms : i n i t i a l a n d a f t e r a n t i t h y r o i d d r u g me d i c a t i o n . T h e i n i t i a l c o r o n a r y a n g i o g r a p h y s h o we d a 9 0 % o c c l u s i o n o f t h e r i g h t c o r o n a r y a r t e r y o s ( A) . On d a y 1 9 a f t e r t h e i n i t i a t i o n o f a n t i t h y r o i d d r u g me d i c a t i o n , c o r o n a r y a n g i o g r a p h y i n d i c a t e d n o r ma l c o r o n a r y a r t e r i e s wi t h a p a t e n t p r e v i o u s g r a f t ( B ) . T h e a r r o ws d e n o t e t h e s a me c o r o n a r y a r t e r y l e s i o n b e f o r e a n d a f t e r t h e a n t i t h y r o i d me d i c a t i o n .
and decreases in alpha-receptors in animal models (14) . (16) 
Thyrotoxicosis leads to vasoconstriction by inhibition of parasympathetic nerves that initiates vasodilation (15). Coronary vasospasm increases the risk of atherosclerotic events by accelerating thrombus formation and delaying fibrinolysis
